Document is current
Any future updates will be listed below
-
Authors
Liu, Rui
Xu, Shi
Liu, Shang
Xu, Mengwei
Li, Jing
Wang, Aili
Li, Wei
Zhan, Lingzhi
Ruan, Keyue
Fei, Caiyi
Wu, Zengding
Han, Tiyun
Cai, Yafei
-
Funding
Funding for this research was provided by:
Start-up grant from Nanjing Agricultural University (804090)
- License Information
-
More Information
Article History
Received: 9 July 2025
Accepted: 6 December 2025
First Online: 31 December 2025
Competing interests
: S.X., S.L., M.X., J.L., A.W., W.L., L.Z., K.R., C.F., Z.W. and T.H. are full-time employees of Nanjing Chengshi (TheraRNA) Biomedical Technology Co. Ltd. Nanjing Chengshi (TheraRNA) Biomedical Technology Co. Ltd. has filed patent for K. pneumoniae mRNA vaccine, E. coli mRNA vaccine, and Salmonella mRNA vaccine, listing Tiyun Han, Shi Xu, Jing Li, Mengwei Xu, and Caiyi Fei as co-inventors.
